This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Search results
From Proteopedia
You searched for Kozisek,_M.
There is no page with the exact title "Kozisek,_M.". The search results for "Kozisek,_M." are displayed below. You can create a page titled Kozisek,_M. (by clicking on the red link).
For more information about searching Proteopedia, see Help.
To exclude pages titled with 4-character PDB codes, use the checkbox "only Human created pages" at the bottom of this page.
Showing below up to 20 results starting with #1.
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
Article title matches
- Category:Kozisek M (40 bytes)
1: List of pages with the keyword Kozisek M - Category:Kozisek, M (41 bytes)
1: List of pages with the keyword Kozisek, M
Page text matches
- 1ztz (11,666 bytes)
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
26: ... and potent inhibitors of HIV protease.,Cigler P, Kozisek M, Rezacova P, Brynda J, Otwinowski Z, Pokorna J,...
44: [[Category: Kozisek M]] - 2hkf (5,544 bytes)
5: ...h sequence from [https://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic infor...
25: ...der P, Collard R, Fabry M, Horejsi M, Rezacova P, Kozisek M, Zavada J, Sedlacek J, Rulisek L, Brynda J Prot... - 2hkh (5,157 bytes)
5: ...h sequence from [https://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic infor...
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
24: ...der P, Collard R, Fabry M, Horejsi M, Rezacova P, Kozisek M, Zavada J, Sedlacek J, Rulisek L, Brynda J Prot... - 2pyn (11,557 bytes)
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
26: ...ics of nelfinavir-resistant HIV protease mutants.,Kozisek M, Bray J, Rezacova P, Saskova K, Brynda J, Pokor...
39: [[Category: Kozisek M]] - 2pym (11,556 bytes)
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
26: ...ics of nelfinavir-resistant HIV protease mutants.,Kozisek M, Bray J, Rezacova P, Saskova K, Brynda J, Pokor...
39: [[Category: Kozisek M]] - 2q64 (11,556 bytes)
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
26: ...ics of nelfinavir-resistant HIV protease mutants.,Kozisek M, Bray J, Rezacova P, Saskova K, Brynda J, Pokor...
39: [[Category: Kozisek M]] - 2q63 (11,556 bytes)
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
26: ...ics of nelfinavir-resistant HIV protease mutants.,Kozisek M, Bray J, Rezacova P, Saskova K, Brynda J, Pokor...
39: [[Category: Kozisek M]] - 2qak (9,109 bytes)
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
28: [[Category: Kozisek M]] - 2qhc (4,903 bytes)
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
26: ... to HIV protease inhibitor lopinavir.,Saskova KG, Kozisek M, Lepsik M, Brynda J, Rezacova P, Vaclavikova J,...
39: [[Category: Kozisek M]] - 2rkf (4,983 bytes)
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
26: ...tease mutants with insertions in the flap region.,Kozisek M, Saskova KG, Rezacova P, Brynda J, van Maarseve...
39: [[Category: Kozisek M]] - 2rkg (4,929 bytes)
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
26: ...tease mutants with insertions in the flap region.,Kozisek M, Saskova KG, Rezacova P, Brynda J, van Maarseve...
39: [[Category: Kozisek M]] - 2z54 (11,531 bytes)
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
26: ... to HIV protease inhibitor lopinavir.,Saskova KG, Kozisek M, Lepsik M, Brynda J, Rezacova P, Vaclavikova J,...
42: [[Category: Kozisek M]] - 3ggu (11,313 bytes)
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
26: ... to the protease inhibitor darunavir.,Saskova KG, Kozisek M, Rezacova P, Brynda J, Yashina T, Kagan RM, Kon... - 3i8w (10,627 bytes)
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
26: ...tallacarboranes.,Rezacova P, Pokorna J, Brynda J, Kozisek M, Cigler P, Lepsik M, Fanfrlik J, Rezac J, Grant... - 3t11 (8,568 bytes)
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
21: [[Category: Kozisek M]] - 3t3c (11,006 bytes)
17: ...iral fitness caused by a highly mutated protease.,Kozisek M, Henke S, Saskova KG, Jacobs GB, Schuch A, Buch...
33: [[Category: Kozisek, M]] - 3ttp (10,569 bytes)
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
16: ... heavily mutated patient-derived HIV-1 proteases.,Kozisek M, Lepsik M, Grantz Saskova K, Brynda J, Konvalin...
31: [[Category: Kozisek M]] - 3u7s (8,675 bytes)
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
21: [[Category: Kozisek M]] - 3bxh (5,227 bytes)
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
26: ... of several glycolytic intermediates.,Rezacova P, Kozisek M, Moy SF, Sieglova I, Joachimiak A, Machius M, O... - 3bxg (5,174 bytes)
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
26: ... of several glycolytic intermediates.,Rezacova P, Kozisek M, Moy SF, Sieglova I, Joachimiak A, Machius M, O...
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
You may also try
